Future Outlook of Checkpoint Receptor Inhibitors
نویسندگان
چکیده
منابع مشابه
Future Directions and Outlook
We are currently conducting experiments to discriminate more phonemes, and evaluate the performance under the constraints imposed by limited computational precision. In addition, we will evaluate the performance of the model when trained on cochleagrams of the signal, rather than DFT's. Finally, we are planning to extend the model to deal naturally with time-dependence, making use of the tempor...
متن کاملJapanese National Initiatives, Future Outlook
The year 2001 signaled the end of Japans Micromachine Technology Project (MTP), and the beginning of a new era in Japanese development of microand nano-technologies and systems. When launched in 1991, the MTP initiative influenced the landscape of MEMS and microsystems technologies not only in Japan but in the rest of the world as well. One of the most powerful industrial nations in the world ...
متن کاملCardiotoxicity of immune checkpoint inhibitors
Cardiac toxicity after conventional antineoplastic drugs (eg, anthracyclines) has historically been a relevant issue. In addition, targeted therapies and biological molecules can also induce cardiotoxicity. Immune checkpoint inhibitors are a novel class of anticancer drugs, distinct from targeted or tumour type-specific therapies. Cancer immunotherapy with immune checkpoint blockers (ie, monocl...
متن کاملAurora Kinase Inhibitors: Current Status and Outlook
The Aurora kinase family comprises of cell cycle-regulated serine/threonine kinases important for mitosis. Their activity and protein expression are cell cycle regulated, peaking during mitosis to orchestrate important mitotic processes including centrosome maturation, chromosome alignment, chromosome segregation, and cytokinesis. In humans, the Aurora kinase family consists of three members; A...
متن کاملCheckpoint inhibitors in hematological malignancies
Inhibitory molecules such as PD-1, CTLA-4, LAG-3, or TIM-3 play a role to keep a balance in immune function. However, many cancers exploit such molecules to escape immune surveillance. Accumulating data support that their functions are dysregulated in lymphoid neoplasms, including plasma cell myeloma, myelodysplastic syndrome, and acute myeloid leukemia. In lymphoid neoplasms, aberrations in 9p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Tumor Medicine & Prevention
سال: 2018
ISSN: 2575-890X
DOI: 10.19080/jtmp.2018.02.555596